·The Hindu·15 marks·250–350 wordsS&T

What are the methodological and ethical challenges in extracting pathogen genomes from ancient human remains?

In this answer
  1. Methodological challenges
  2. Ethical challenges

Palaeogenomics — recovering ancient DNA (aDNA) from skeletal or mummified remains — has begun rewriting epidemic history. The 2026 Science study recovering the first smallpox (Orthopoxvirus variola) genomes of the Americas from two mummified individuals in northern Chile, dated 1492–1631 CE [1], illustrates both the payoff and the twin technical and ethical hurdles such work faces.

Methodological challenges

  • Degradation: aDNA survives only as short, chemically damaged fragments, demanding deep sequencing and damage-pattern authentication to separate genuine ancient reads from noise.
  • Low pathogen signal: viral DNA is a minute fraction against human and soil-microbe background; the Chilean variola find was accidental, emerging from a study aimed at population ancestry [1].
  • Contamination by modern DNA and handling requires clean-room protocols and strict controls.
  • Dating and clock calibration: lineage divergence (~1296 CE) must not be conflated with the infection date (1492–1631 CE); substitution rates themselves shift — steady gene inactivation till the late 16th century, then constraint and rebound [1].
  • Preservation bias: arid, cold sites like the Atacama preserve remains; tropical regions rarely yield genomes, skewing the global disease map.

Ethical challenges

  • Destructive sampling: bone is irreversibly consumed, conflicting with the custodial duty toward ancestral remains.
  • Consent and community rights: the dead cannot consent; UNDRIP Article 12 affirms Indigenous peoples' rights over ceremonial objects and repatriation of human remains, implying prior consultation with descendant communities [3].
  • Sovereignty and benefit-sharing: the Nagoya Protocol's access-and-benefit-sharing norms caution against "helicopter research" that exports samples without returning gains to source nations [4].
  • Stigmatisation of descendant groups linked to disease, and biosecurity risk from published sequences of an eradicated pathogen whose live stocks WHO keeps under tight control [2].

Ancient pathogen genomics converts contested colonial narratives into hard evidence, but its legitimacy rests on how the remains are treated. A community-partnered model — minimally destructive sampling, prior informed consent, data co-ownership and eventual repatriation, framed by UNDRIP and Nagoya norms — lets the discipline serve both scientific truth and historical justice.

Sources

  1. 1The genomic identity of early smallpox in South America — *Science* (2026), doi:10.1126/science.aee6957first American variola genomes, 1492–1631 CE dating, ~1296 CE lineage divergence, accidental discovery, substitution-rate shifts
  2. 2WHO — Smallpox (health topic)eradication and continued regulation of variola virus stocks; biosecurity concern
  3. 3United Nations Declaration on the Rights of Indigenous Peoples, Article 12Indigenous rights over human remains and repatriation
  4. 4Nagoya Protocol on Access to Genetic Resources and Benefit-Sharing, CBDsovereign rights over genetic resources, fair and equitable benefit-sharing

More from this note

More on S&T